BiotechTube
Home/Pipeline/CBD Treatment for Severe COVID‑19

CBD Treatment for Severe COVID‑19

Severe COVID‑19

Phase 1/2 completed, Phase 2b upcomingActive

Key Facts

Indication
Severe COVID‑19
Phase
Phase 1/2 completed, Phase 2b upcoming
Status
Active
Company
Stero Biotechs

About Stero Biotechs

CBD‑driven steroid‑sparing therapies for inflammatory and autoimmune diseases.

View full company profile

Therapeutic Areas

ImmunologyInflammatory diseasesGastroenterologyDermatologyInfectious diseases

Other Severe COVID‑19 Drugs

DrugCompanyPhase
SB-001AcadeMab BiomedicalPreclinical